EMGESAN

Main information

  • Trade name:
  • EMGESAN 250 mg tablet
  • Dosage:
  • 250 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • No Prescription (OTC)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EMGESAN 250 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Magnesium hydroxide
  • Product summary:
  • Suitability for use in older adult patients Magnesii hydroxidum Avoid using in older persons. Reduce the dose in moderate and severe renal insufficiency. Take the several interactions in the absorption phase into account.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 9140
  • Authorization date:
  • 02-10-2006
  • Last update:
  • 21-02-2018